<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="116175">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02151968</url>
  </required_header>
  <id_info>
    <org_study_id>USG123</org_study_id>
    <nct_id>NCT02151968</nct_id>
  </id_info>
  <brief_title>Traditional Blind Versus Ultrasound-guided Peribulbar Blockade</brief_title>
  <official_title>Traditional Blind Versus Ultrasound-guided Peribulbar Blockade</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sunnybrook Health Sciences Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sunnybrook Health Sciences Centre</source>
  <oversight_info>
    <authority>Canada: Health Canada</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Eye surgeries are traditionally performed under local anaesthesia with a peribulbar block.
      This is a blind technique where local anaesthetic is injected into the back of the eye to
      make the eye numb and motionless for surgery.  This is a blind injection and can be
      associated with complications such as bleeding, rupture of eye globe, blindness, increasing
      the pressure of the eye etc.  It also has a high failure rate resulting in need for
      additional injections, further exposing the patient to possible complications.  The
      investigators propose to perform the peribulbar block with ultrasound to guide the block
      needle placement and injection.  The investigators hypothesize that ultrasound guided
      peribulbar blocks would have higher success rate (less need for additional injections) and
      that the total amount of local anaesthetics used would be decreased.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>July 2014</start_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Failure of peribulbar block</measure>
    <time_frame>10 minutes after block performed</time_frame>
    <safety_issue>No</safety_issue>
    <description>Ocular Anaesthetic Scoring System (OASS) score of less than 10 will be considered inadequate for surgery and a block failure.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of the block</measure>
    <time_frame>5 and 10 min after block performed</time_frame>
    <safety_issue>No</safety_issue>
    <description>Quality of the block based on the OASS score will be classified as poor (0-3), average (4-9) and good (10-14).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Supplemental Peribulbar injections</measure>
    <time_frame>Operative day 0</time_frame>
    <safety_issue>No</safety_issue>
    <description>To determine incidence of additional peribulbar injections after failure of original block as determined preoperatively by the anaesthetist or intraoperatively by the surgeon.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Volume of Total Local Anaesthetic Used</measure>
    <time_frame>Operative day 0</time_frame>
    <safety_issue>No</safety_issue>
    <description>The total volume of local anaesthetic used for peribulbar block preoperatively and intraoperatively.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Retinal and Infra-ocular Pathology</condition>
  <arm_group>
    <arm_group_label>Traditional blind peribulbar block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Ultrasound-guided peribulbar block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Local Anaesthetic Injection</intervention_name>
    <description>Local anaesthetic is injected into the eye.</description>
    <arm_group_label>Traditional blind peribulbar block</arm_group_label>
    <arm_group_label>Ultrasound-guided peribulbar block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ultrasound-Guidance</intervention_name>
    <description>Device: Ultrasound Machine
Peribulbar block local anaesthetic is injected into the eye with ultrasound guidance.</description>
    <arm_group_label>Ultrasound-guided peribulbar block</arm_group_label>
    <other_name>Ultrasound Machine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing vitrectomy surgery

        Exclusion Criteria:

          -  Lack of informed consent

          -  Coagulopathic disorder, anticoagulated with INR (international normalized ratio) &gt;
             1.5 or platelet count less than 75 x 10^9/L

          -  Pathological myopia.  Inability of patient to lie down for 2 hours for the operation
             -Local infection at site of needle entry
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Sunnybrook Health Sciences Centre</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M4N 3M5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Paul McHardy, MD</last_name>
      <phone>416-480-6100</phone>
      <phone_ext>pg x 6626</phone_ext>
      <email>paul.mchardy@sunnybrook.ca</email>
    </contact>
    <investigator>
      <last_name>Paul McHardy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Steven Lee, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Peter Kertes, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kenneth Eng, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 28, 2014</lastchanged_date>
  <firstreceived_date>May 20, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sunnybrook Health Sciences Centre</investigator_affiliation>
    <investigator_full_name>Dr. Paul McHardy</investigator_full_name>
    <investigator_title>Lecturer</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anesthetics, Local</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
